Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Research & Development (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Research & Development for 12 consecutive years, with $47.4 million as the latest value for Q1 2026.

  • For Q1 2026, Research & Development rose 16.78% year-over-year to $47.4 million; the TTM value through Mar 2026 reached $189.6 million, up 13.63%, while the annual FY2025 figure was $182.8 million, 14.46% up from the prior year.
  • Research & Development hit $47.4 million in Q1 2026 for Wave Life Sciences, down from $52.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $52.8 million in Q4 2025 and bottomed at $27.5 million in Q1 2022.
  • Average Research & Development over 5 years is $37.4 million, with a median of $34.1 million recorded in 2023.
  • Year-over-year, Research & Development dropped 17.74% in 2022 and then soared 31.02% in 2024.
  • Wave Life Sciences' Research & Development stood at $31.1 million in 2022, then increased by 9.64% to $34.1 million in 2023, then skyrocketed by 31.02% to $44.6 million in 2024, then grew by 18.3% to $52.8 million in 2025, then decreased by 10.18% to $47.4 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $47.4 million, $52.8 million, and $45.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.